Target animal safety test of a dexamethasone-prednisolone combination in horses.
Abstract: The target animal safety of a dexamethasone-prednisolone combination was studied on 12 horses divided into two groups of six each. One group of horses received the therapeutic dose of the combination (25 mg/animal dexamethasone pivalate and 75 mg/animal prednisolone) and the second group was given the threefold dose of it. The preparation was administered intravenously for 2 consecutive days. For assessment of safety a wide range of clinical, haematological, biochemical and urine variables were tested as laid down in the guidelines of the FDA. All horses treated by the therapeutic or the threefold therapeutic doses of the preparation remained in good health throughout the entire study. No signs of clinical abnormalities occurred in either group. The physiological variables tested failed to reveal any significant alteration as a consequence of the medications. Of the haematological and biochemical parameters leucocyte, neutrophil, eosinophil and lymphocyte counts, aspartate aminotransferase activity, glucose, phosphor, total and conjugated bilirubin and creatinine concentrations were significantly affected in both groups. In some animals a transient glucosuria occurred. From the direction and magnitude of these changes it was concluded that they did not reflect any toxic actions of the preparation. Nevertheless, the combination is to be administered only with exact therapeutic indications and the uncontrolled misuse of it must be avoided.
Publication Date: 1990-09-01 PubMed ID: 2242726
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research investigates the safety of a combination of dexamethasone and prednisolone in horses, confirming that this medication cocktail did not result in significant adverse effects, although precaution should be maintained to avoid misuse.
Experiment Design and Setup
- The research was set up to evaluate the safety of a combined dose of dexamethasone and prednisolone in two groups of six horses each.
- One group was given the therapeutic dose of the medication (25 mg/animal of dexamethasone pivalate and 75 mg/animal of prednisolone), while the second group was given a dose three times that.
- Both doses were administered intravenously over a period of two consecutive days, and the health of the horses was closely monitored throughout this period.
Clinical, Haematological, and Biochemical Testing
- For the sake of thorough safety assessment, a wide array of variables were tested, all according to FDA guidelines. These included clinical, haematological, biochemical, and urine-related variables.
- The research found that all of the horses, regardless of which group they were a part of, remained in good health throughout the study.
- None of the horses in either group showed any signs of clinical abnormalities, and testing of physiological variables did not indicate any significant changes as a result of either dose of the medication.
Significant Findings
- The results did, however, reveal that certain haematological and biochemical parameters- specifically, leucocyte, neutrophil, eosinophil and lymphocyte counts, aspartate aminotransferase activity, glucose, phosphor, total and conjugated bilirubin and creatinine concentrations- were notably affected in both groups of horses.
- In certain horses, the medication did result in a temporary case of glucosuria (excess glucose in urine). Nevertheless, the researchers established that these changes did not indicate any toxic effects from the medication combination.
Concluding Remarks and Recommendations
- Although the research confirms the safety of the combination of dexamethasone and prednisolone in horses, the experts stress that it should be administered only with exact therapeutic indications.
- The study emphasizes that uncontrolled misuse of the medication must be avoided, highlighting the ongoing need for precaution and care in the administration of this specific combination.
Cite This Article
APA
Simon F, Laczay P, Móra Z, Lehel J.
(1990).
Target animal safety test of a dexamethasone-prednisolone combination in horses.
Dtsch Tierarztl Wochenschr, 97(9), 339-342.
Publication
Researcher Affiliations
- Department of Pharmacology and Toxicology, University of Veterinary Medicine Budapest, Hungary.
MeSH Terms
- Animals
- Blood Cell Count / drug effects
- Blood Cell Count / veterinary
- Blood Cells / drug effects
- Blood Chemical Analysis / veterinary
- Dexamethasone / toxicity
- Drug Combinations
- Female
- Horses / blood
- Male
- Prednisolone / toxicity
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists